Autres langues LeMaitre Vascular, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 19/04/2024			Varia. 5j.	Varia. 1 janv.
63,26 ^USD	+1,02 %		-2,15 %	+11,45 %

12/03	Un initié de Lemaitre Vascular a vendu des actions pour une valeur de 309 684 $, selon un récent dépôt auprès de la SEC	MT
07/03	Un initié de Lemaitre Vascular a vendu des actions pour une valeur de 344 925 $, selon un récent dépôt auprès de la SEC	MT

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024	19/04
LeMaitre Vascular : Proxy Statement for 2024 Annual Meeting	16/04
LeMaitre Vascular : Proxy Card for 2024 Annual Meeting	16/04
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference	26/03
Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	12/03
Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing	07/03
Lemaitre Vascular Insider Sold Shares Worth $517,500, According to a Recent SEC Filing	07/03
LeMaitre to Participate at Upcoming Investor Conferences in March	01/03
Health Care Drops After Mixed Earnings -- Health Care Roundup	28/02
LeMaitre: Q4 Earnings Snapshot	27/02
LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on March 28, 2024	27/02
LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	27/02
LeMaitre Vascular, Inc. announces an Equity Buyback for $50 million worth of its shares.	27/02
LeMaitre Vascular, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
(LMAT) LEMAITRE VASCULAR Forecasts Fiscal Year 2024 EPS $1.65	27/02
(LMAT) LEMAITRE VASCULAR Expects Q1 EPS $0.28	27/02
Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q4 Revenue $48.9M, vs. Street Est of $49M	27/02
LeMaitre Q4 2023 Financial Results	27/02
LeMaitre Vascular, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
LeMaitre Vascular, Inc. authorizes a Buyback Plan.	21/02

Aucun résultat pour cette recherche